Abstract
Get full access to this article
View all access options for this article.
References
1.
Mehta
A
Ricci
R
Widmer
U
, et al .
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey . Eur J Clin Invest 2004 ;
34 : 236 –242 .
2.
Hannah
J
Sangle
S
D’Cruz
D.
81. Fabry disease presenting as autoimmune rheumatic disease. Rheumatol Adv Pract 2018 ;
2 : rky34.044 .
3.
Martinez
P
Aggio
M
Rozenfeld
P.
High incidence of autoantibodies in Fabry disease patients . J Inherit Metab Dis 2007 ;
30 : 365 –369 .
4.
Rahman
P
Gladman
DD
Wither
J
Silver
MD.
Coexistence of Fabry’s disease and systemic lupus erythematosus . Clin Exp Rheumatol 1998 ;
16 : 475 –478 .
5.
Waggoner
T
Waggoner
DK
Guma
DM
Kim
DU
Byrd
L.
Clinical mimicry: Fabry disease masquerading as lupus? J Musculoskeletal Med 2010 ;
27 : 1 –5 .
6.
Whybra
C
Kampmann
C
Willers
I
, et al .
Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes . J Inherit Metab Dis 2001 ;
24 : 715 –724 .
7.
Kiykim
E
Şahin
S
Zubarioğlu
T
, et al .
Screening for Fabry disease in patients with juvenile systemic lupus erythematosus . Arch Rheumatol 2020 ;
35 : 7 –12 .
8.
Svarstad
E
Marti
HP.
The changing landscape of Fabry disease . Clin J Am Soc Nephrol 2020 ;
15 : 569 –576 .